95 related articles for article (PubMed ID: 16541142)
41. Glucocorticoid receptor alpha, beta and gamma expression vs in vitro glucocorticod resistance in childhood leukemia.
Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ
Leukemia; 2004 Mar; 18(3):530-7. PubMed ID: 14724649
[TBL] [Abstract][Full Text] [Related]
42. Proteome analysis on an early transformed human bronchial epithelial cell line, BEP2D, after alpha-particle irradiation.
Ying W; Zhang K; Qian X; Xie L; Wang J; Xiang X; Cai Y; Wu D
Proteomics; 2003 Jan; 3(1):64-72. PubMed ID: 12548635
[TBL] [Abstract][Full Text] [Related]
43. [Differential proteomic analysis of human lung adenocarcinoma cell line A-549 and of normal cell line HBE].
Zhan XQ; Guan YJ; Li C; Chen ZC; Xie JY; Chen P; Liang SP
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jan; 34(1):50-6. PubMed ID: 11958134
[TBL] [Abstract][Full Text] [Related]
44. [Comparative proteomics of the serum in patients with nasopharyngeal carcinoma: a study with two-dimensional electrophoresis and MALDI-TOF-MS].
Liao QL; Chen XD; Zhao L; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):154-8. PubMed ID: 18250030
[TBL] [Abstract][Full Text] [Related]
45. Good early treatment response in childhood acute lymphoblastic leukemia is associated with Bax nuclear accumulation and PARP cleavage.
Urasiński T; Urasińska E; Grabarek J; Fydryk J; Domagała W
Med Sci Monit; 2009 Jun; 15(6):CR294-301. PubMed ID: 19478700
[TBL] [Abstract][Full Text] [Related]
46. Differential protein analysis of lymphocytes between children with acute lymphoblastic leukemia and healthy children.
Wang D; Lv YQ; Liu YF; Du XJ; Li B
Leuk Lymphoma; 2013 Feb; 54(2):381-6. PubMed ID: 22812402
[TBL] [Abstract][Full Text] [Related]
47. Determination of the in vivo effects of prednisone on Bcl-2 family protein expression in childhood acute lymphoblastic leukemia.
Casale F; Addeo R; D'Angelo V; Indolfi P; Poggi V; Morgera C; Crisci S; Di Tullio MT
Int J Oncol; 2003 Jan; 22(1):123-8. PubMed ID: 12469194
[TBL] [Abstract][Full Text] [Related]
48. Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia.
Serafin V; Capuzzo G; Milani G; Minuzzo SA; Pinazza M; Bortolozzi R; Bresolin S; Porcù E; Frasson C; Indraccolo S; Basso G; Accordi B
Blood; 2017 Dec; 130(25):2750-2761. PubMed ID: 29101238
[TBL] [Abstract][Full Text] [Related]
49. Single nucleotide polymorphisms in non-coding region of the glucocorticoid receptor gene and prednisone response in childhood acute lymphoblastic leukemia.
Xue L; Li C; Wang Y; Sun W; Ma C; He Y; Yu Y; Cai L; Wang L
Leuk Lymphoma; 2015 Jun; 56(6):1704-9. PubMed ID: 25644744
[TBL] [Abstract][Full Text] [Related]
50. The MIF-173G/C polymorphism does not contribute to prednisone poor response in vivo in childhood acute lymphoblastic leukemia.
Ziino O; D'Urbano LE; De Benedetti F; Conter V; Barisone E; De Rossi G; Basso G; Aricò M
Leukemia; 2005 Dec; 19(12):2346-7. PubMed ID: 16208413
[No Abstract] [Full Text] [Related]
51. Simultaneous assessment of p53 and MDM2 expression in leukemic cells in response to initial prednisone therapy in children with acute lymphoblastic leukemia.
Ociepa T; Maloney E; Kamieńska E; Wysocki M; Kurylak A; Matysiak M; Urasiński T; Urasińska E; Domagała W
Pol J Pathol; 2010; 61(4):199-205. PubMed ID: 21290342
[TBL] [Abstract][Full Text] [Related]
52. NFkappaB modulators in a model of glucocorticoid resistant, childhood acute lymphoblastic leukemia.
Nicholson L; Hall AG; Redfern CP; Irving J
Leuk Res; 2010 Oct; 34(10):1366-73. PubMed ID: 20106524
[TBL] [Abstract][Full Text] [Related]
53. The role of AP-1 in glucocorticoid resistance in leukaemia.
Bailey S; Hall AG; Pearson AD; Redfern CP
Leukemia; 2001 Mar; 15(3):391-7. PubMed ID: 11237062
[TBL] [Abstract][Full Text] [Related]
54. Glucocorticoids induce G1 arrest of lymphoblastic cells through retinoblastoma protein Rb1 dephosphorylation in childhood acute lymphoblastic leukemia in vivo.
Addeo R; Casale F; Caraglia M; D'Angelo V; Crisci S; Abbruzzese A; Di Tullio MT; Indolfi P
Cancer Biol Ther; 2004 May; 3(5):470-6. PubMed ID: 15034294
[TBL] [Abstract][Full Text] [Related]
55. Identification of prognostic protein biomarkers in childhood acute lymphoblastic leukemia (ALL).
Jiang N; Kham SK; Koh GS; Suang Lim JY; Ariffin H; Chew FT; Yeoh AE
J Proteomics; 2011 May; 74(6):843-57. PubMed ID: 21396490
[TBL] [Abstract][Full Text] [Related]
56. Hydrocortisone does not influence glucocorticoid sensitivity of acute lymphoblastic leukemia cells.
Warris LT; van den Heuvel-Eibrink MM; Ariës IM; Pieters R; van den Akker EL; den Boer ML
Haematologica; 2015 Apr; 100(4):e137-9. PubMed ID: 25425687
[No Abstract] [Full Text] [Related]
57. Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia.
Gaynon PS; Carrel AL
Adv Exp Med Biol; 1999; 457():593-605. PubMed ID: 10500839
[TBL] [Abstract][Full Text] [Related]
58. [Analysis of the different proteomes between the acute leukemia cells and normal white blood cells].
Cui JW; Wang GJ; Li W; Wang J; Zhang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):201-7. PubMed ID: 16638180
[TBL] [Abstract][Full Text] [Related]
59. [Clinical, morphologic immunologic and cytogenetic characteristics of childhood acute lymphoblastic leukemia: a comparison between prednisone poor responders and good responders].
Liu HT; Li Q; Guo X
Zhonghua Er Ke Za Zhi; 2007 Nov; 45(11):865-7. PubMed ID: 18282425
[No Abstract] [Full Text] [Related]
60. Expression of heat shock proteins, glutathione peroxidase and catalase in childhood acute lymphoblastic leukemia and nephroblastoma.
Stammler G; Volm M
Cancer Lett; 1996 Jan; 99(1):35-42. PubMed ID: 8564927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
